HIV/AIDS Care Team, Training Program Pivot During Pandemic Dec. 1, 2021 Pandemic-related changes helped provide a continuum of care, while also reducing clinic “no-shows.” Read more Image
COVID-19 Antiviral Drugs Dec. 1, 2021 Jun Wang, PhD, associate professor of pharmacology and toxicology at the R. Ken Coit College of Pharmacy, explains how the new antiviral pills from Merck and Pfizer fit into the framework of existing COVID-19 therapies. SciLine
Biden Outlines New Steps to Combat COVID-19 Through Winter Months Dec. 1, 2021 President Joe Biden's multi-pronged approach puts a heavy emphasis on expanding vaccinations to Americans who have resisted getting shots and to provide boosters to all adults. "We need more at-home testing,” said Shad Marvasti, MD, associate professor and director of the public health, prevention. population health curriculum at the College of Medicine – Phoenix. KTKV/KPHO (Phoenix, AZ)
Omicron Could Threaten COVID-19 Immunity — But We’re Not Going Back to ‘Square One’ Dec. 1, 2021 Immunologists and virologists say that while it will still take time to determine the variant's real-world impact, our immunity from vaccines and prior infection could take a significant hit if it takes off globally. "I wouldn't say that this one's going to put us back to zero," said Deepta Bhattacharya, PhD, a professor and immunobiologist at the College of Medicine – Tucson. "But I do think that if it does spread, it's going to be a bigger problem than any of the variants we've seen before." Canadian Broadcasting Corporation (CBC)
University of Arizona Joins Clinical Trial to Evaluate Aiberry AI Platform’s Ability to Detect Depression Dec. 1, 2021 Allison J. Huff, DHEd, assistant professor in the Department of Family and Community Medicine at the College of Medicine – Tucson, is involved in a clinical trial using artificial intelligence technology that analyzes a patient’s words, voice, and facial expressions to detect mental health conditions and integrates with telehealth services. AZoRobotics
‘Interesting and Important’ Results from AVATAR Trial Presented at AHA Dec. 1, 2021 Nancy K. Sweitzer, MD, PhD, director of the UArizona Sarver Heart Center, discusses results from the AVATAR trial presented at this year’s American Heart Association Scientific Sessions. The trial evaluated surgical aortic valve replacement among asymptomatic patients with severe aortic stenosis. Healio
University of Arizona Joins Clinical Study to Test Aiberrys AI Platform to Detect Mental Illness Nov. 30, 2021 Allison J. Huff, DHEd, assistant professor in the Department of Family and Community Medicine at the College of Medicine – Tucson, is involved in a clinical trial using artificial intelligence technology that analyzes a patient’s words, voice, and facial expressions to detect mental health conditions and integrates with telehealth services. User Walls
Exploring the Connection Between Endometriosis and the Gut Microbiome Nov. 30, 2021 Although bacteria are altered in endometriosis, there is no definitive consensus on specific microbiota compositions linked to the disease, according to a review in Human Reproduction Update. “We want to encourage more robust microbiome research for endometriosis because it is an incredibly burdensome condition that warrants additional attention and research,” said senior author Melissa Herbst-Kralovetz, PhD, director of the Women’s Health Research Program and Microbiome Initiative at the College of Medicine – Phoenix. Contemporary OB/GYN
Meet a Navajo Student Advancing Indigenous Rights Around Research Data Nov. 30, 2021 Dynnika Tso (Diné) is a public health undergraduate student at the University of Arizona Health Sciences who is passionate about improving ethical standards in research. Read more Image